Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
QARZIBA 20.25 mg/4.5ml Konz Inf Durchstf 1 Stk
Drug
Qarziba, Konzentrat zur Herstellung einer Infusionslösung
Neuroblastoma
07.16.1. – cytostatics
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
4/18/2024
4/17/2029
Dosage strength
Qarziba 20,25 mg/4,5 ml, Konzentrat zur Herstellung einer Infusionslösung
Neuroblastoma
01
Z – approved
Package
7680674630012
In trade from / since 4/18/2024
A/R – Authorised / referenced
1 bottle(s)
001
Z – approved
Declaration
Component
20.25 mg dinutuximabum beta
saccharum
histidinum
polysorbatum 20
acidum hydrochloridum
aqua ad iniectabile
histidinum
polysorbatum 20
acidum hydrochloridum
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
8602.80
None
Yes
10%
No
Authorisation holder
7601001352742
Medius AG
Stegackerstrasse 1
4132 Muttenz (BL)
Stegackerstrasse 1
4132 Muttenz (BL)
Date of the last update to the medicines data
3/4/2026
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.